West Harlem’s Volastra Therapeutics Appoints Charles Hugh-Jones As New CEO

Volastra Therapeutics, a biotechnology company developing novel therapies to treat and prevent the formation of metastatic disease, has named Charles Hugh-Jones, MD, FRCP, as its Chief Executive Officer. Continue Reading →

Benjamin Lipschitz Named General Counsel And Interim Compliance Officer For START Treatment & Recovery Centers

Benjamin Lipschitz has been named general counsel and interim compliance officer for START Treatment & Recovery Centers, a non-profit and New York’s largest independent drug treatment agency. Continue Reading →


Get the best updates with the Harlem World Editor's Picks.